Previous | Next
Part: 12 Session: 145678910111213141516171819202122 Page 793794795796797798799800801802803804805806807808809810811812813814815816817818819820821822823824825826827828829830831832833834835836837838839840841842843844845846847848849850851852853854855856857858859860 of 999
Did you make a speech?
I forget now whether I made a speech, but I certainly praised them. There was an international symposium on atherosclerosis at Houston last fall, to which I went for some sessions, and I must say that there is no focus, not tremendous expectations in the field of atherosclerosis as there is amount people interested in interferons in relation to cancer and virus diseases.
Now many people don't understand anything about interferon, and they don't really care, but the people that understand something about it have fantastic expectations that this is going to be a revolution in the treatment of viral diseases and cancer.
But now with the condition of the blood vessels, you told me about five years ago that there was somebody on the West Coast working with a drug which would dissolve the residue in the arteries.
There is, there is a drug, but it is very hard to take.
It has side effects?
It has side effects that are so definitely severe that it's impractical. Now I don't know this, but I doubt
© 2006 Columbia University Libraries | Oral History Research Office | Rights and Permissions | Help